Cited by 491Health Systems, Economic Evaluations, Quality of LifeDiabetes Management and EducationDiabetes Treatment and Management

The DOI matches its Crossref record; 84 of the 87 references it cites were found in a registry or an index.

Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review

Open access

Li, Rui, Zhang, Ping, Barker, Lawrence E., Chowdhury, Farah M., Zhang, Xuanping·2010·Diabetes Care

DOI 10.2337/dc10-0843PMC PMC2909081

Open this paper in CoChat — free account

Abstract

OBJECTIVE: To synthesize the cost-effectiveness (CE) of interventions to prevent and control diabetes, its complications, and comorbidities. RESEARCH DESIGN AND METHODS: We conducted a systematic review of literature on the CE of diabetes interventions recommended by the American Diabetes Association (ADA) and published between January 1985 and May 2008. We categorized the strength of evidence about the CE of an intervention as strong, supportive, or uncertain. CEs were classified as cost saving (more health benefit at a lower cost), very cost-effective (≤$25,000 per life year gained [LYG] or quality-adjusted life year [QALY]), cost-effective ($25,001 to $50,000 per LYG or QALY), marginally cost-effective ($50,001 to $100,000 per LYG or QALY), or not cost-effective (>$100,000 per LYG or QALY). The CE classification of an intervention was reported separately by country setting (U.S. or other developed countries) if CE varied by where the intervention was implemented. Costs were measured in 2007 U.S. dollars. RESULTS: Fifty-six studies from 20 countries met the inclusion criteria. A large majority of the ADA recommended interventions are cost-effective. We found strong evidence to classify the following interventions as cost saving or very cost-effective: (I) Cost saving— 1) ACE inhibitor (ACEI) therapy for intensive hypertension control compared with standard hypertension control; 2) ACEI or angiotensin receptor blocker (ARB) therapy to prevent end-stage renal disease (ESRD) compared with no ACEI or ARB treatment; 3) early irbesartan therapy (at the microalbuminuria stage) to prevent ESRD compared with later treatment (at the macroalbuminuria stage); 4) comprehensive foot care to prevent ulcers compared with usual care; 5) multi-component interventions for diabetic risk factor control and early detection of complications compared with conventional insulin therapy for persons with type 1 diabetes; and 6) multi-component interventions for diabetic risk factor control and early detection of complications compared with standard glycemic control for persons with type 2 diabetes. (II) Very cost-effective— 1) intensive lifestyle interventions to prevent type 2 diabetes among persons with impaired glucose tolerance compared with standard lifestyle recommendations; 2) universal opportunistic screening for undiagnosed type 2 diabetes in African Americans between 45 and 54 years old; 3) intensive glycemic control as implemented in the UK Prospective Diabetes Study in persons with newly diagnosed type 2 diabetes compared with conventional glycemic control; 4) statin therapy for secondary prevention of cardiovascular disease compared with no statin therapy; 5) counseling and treatment for smoking cessation compared with no counseling and treatment; 6) annual screening for diabetic retinopathy and ensuing treatment in persons with type 1 diabetes compared with no screening; 7) annual screening for diabetic retinopathy and ensuing treatment in persons with type 2 diabetes compared with no screening; and 8) immediate vitrectomy to treat diabetic retinopathy compared with deferred vitrectomy. CONCLUSIONS: Many interventions intended to prevent/control diabetes are cost saving or very cost-effective and supported by strong evidence. Policy makers should consider giving these interventions a higher priority.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.2337/dc10-0843

Cites

84 of 84 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Department of Labor
Schwarz, S. (1941) · Columbia University Press eBooks · doi:10.7312/schw92626-009 · Cited by 4,698
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)
Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A. D., Vijay, V., & Indian Diabetes Prevention Programme (IDPP) (2006) · Diabetologia · doi:10.1007/s00125-005-0097-z · Cited by 1,881
The Finnish Diabetes Prevention Study (DPS)
Lindström, J., Louheranta, A., Mannelin, M., Rastas, M., Salminen, V., Eriksson, J., Uusitupa, M., Tuomilehto, J., & for the Finnish Diabetes Prevention Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3230 · Cited by 1,848
Guidelines for authors and peer reviewers of economic submissions to the BMJ
Drummond, M. F., & Jefferson, T. O. (1996) · BMJ · doi:10.1136/bmj.313.7052.275 · Cited by 1,827
The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study
Li, G., Zhang, P., Wang, J., Gregg, E. W., Yang, W., Gong, Q., Li, H., Li, H., Jiang, Y., An, Y., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60766-7 · Cited by 1,600
Self-citation
How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.
Laupacis, A., Feeny, D. H., Detsky, A. S., & Tugwell, P. (1992) · Europe PMC (PubMed Central) · Cited by 1,581

Flagged first, then by citations

Show all 87 references

3 of the 87 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Clarke, Cochrane Reviewers' Handbook

Sorted by citations

Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Standards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
Fuller, N. R., Colagiuri, S., SCHOFIELD, D. J., Olson, A. D., Shrestha, R. N., Holzapfel, C., Wolfenstetter, S. B., Holle, R., Ahern, A. L., Hauner, H., et al. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.139 · Cited by 2,127
Cardiovascular Disease and Diabetes: Policies for Better Health and Quality of Care
OECD (2015) · OECD health policy studies · doi:10.1787/9789264233010-en · Cited by 1,388
Diabetes in Older Adults
Kirkman, M. S., Briscoe, V. J., Clark, N., Florez, H., Haas, L. B., Halter, J. B., Huang, E. S., Korytkowski, M. T., Munshi, M. N., Odegard, P. S., et al. (2012) · Diabetes Care · doi:10.2337/dc12-1801 · Cited by 1,274
The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
Chan, J. C. N., Lim, L.-L., Wareham, N. J., Shaw, J. E., Orchard, T. J., Zhang, P., Lau, E. S. H., Eliasson, B., Kong, A. P. S., Ezzati, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32374-6 · Cited by 793
Self-citation
Circulating microRNAs as novel biomarkers for diabetes mellitus
Guay, C., & Regazzi, R. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.86 · Cited by 563
Value of Primordial and Primary Prevention for Cardiovascular Disease: A Policy Statement From the American Heart Association
Weintraub, W. S., Daniels, S. R., Burke, L. E., Franklin, B. A., Goff, D. C., Hayman, L. L., Lloyd-Jones, D., Pandey, D. K., Sanchez, E. J., Schram, A. P., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182285a81 · Cited by 541
Diabetes in Older Adults: A Consensus Report
Sue Kirkman, M., Briscoe, V. J., Clark, N., Florez, H., Haas, L. B., Halter, J. B., Huang, E. S., Korytkowski, M. T., Munshi, M. N., Odegard, P. S., et al. (2012) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12035 · Cited by 548
Diabetes Prevention in the Real World: Effectiveness of Pragmatic Lifestyle Interventions for the Prevention of Type 2 Diabetes and of the Impact of Adherence to Guideline Recommendations
Dunkley, A. J., Bodicoat, D. H., Greaves, C. J., Russell, C., Yates, T., Davies, M. J., & Khunti, K. (2014) · Diabetes Care · doi:10.2337/dc13-2195 · Cited by 542
Introduction: Standards of Medical Care in Diabetes—2018
(2018) · Diabetes Care · doi:10.2337/dc18-sint01 · Cited by 472
Prevention of foot ulcers in the at‐risk patient with diabetes: a systematic review
van Netten, J. J., Price, P., Lavery, L. A., Monteiro‐Soares, M., Rasmussen, A., Jubiz, Y., Bus, S. A., & on behalf of the International Working Group on the Diabetic Foot (IWGDF) (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2701 · Cited by 426
Guidelines for Preventive Activities in General Practice
Ackermann, E. W., Harris, M., Alexander, K. L., Arcus, M., Bailey, L., Bennett, J. W., Mar, C. D., Emery, J. D., Ewald, B. D., Ewald, D. P., et al. (2012) · e-publications@bond (Bond University) · Cited by 421
IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes
Fernandes, J. D. R., Ogurtsova, K., Linnenkamp, U., Guariguata, L., Seuring, T., Zhang, P., Cavan, D. A., & Makaroff, L. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.04.016 · Cited by 377
Self-citation
Macronutrients, Food Groups, and Eating Patterns in the Management of Diabetes
Wheeler, M. L., Dunbar, S. A., Jaacks, L. M., Karmally, W., Mayer-Davis, E. J., Wylie-Rosett, J., & Yancy, W. S. (2012) · Diabetes Care · doi:10.2337/dc11-2216 · Cited by 357
Introduction: Standards of Medical Care in Diabetes—2019
Frías, J. P. (2018) · Diabetes Care · doi:10.2337/dc19-sint01 · Cited by 331
The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
Chan, J. C. N., Lim, L., Wareham, N. J., Shaw, J. E., Orchard, T. J., Zhang, P., Lau, E. S. H., Eliasson, B., Kong, A. P. S., Ezzati, M., et al. (2020) · Figshare · Cited by 337
Self-citation
Introduction: Standards of Medical Care in Diabetes—2020
(2020) · Diabetes Care · doi:10.2337/dc20-sint · Cited by 331
A systematic review of real-world diabetes prevention programs: learnings from the last 15 years
Aziz, Z., Absetz, P., Oldroyd, J. C., Pronk, N. P., & Oldenburg, B. F. (2015) · Implementation Science · doi:10.1186/s13012-015-0354-6 · Cited by 318
Trends in Death Rates Among U.S. Adults With and Without Diabetes Between 1997 and 2006
Gregg, E. W., Cheng, Y. J., Saydah, S., Cowie, C. C., GARFIELD, S. A., Geiss, L. S., & Barker, L. E. (2012) · Diabetes Care · doi:10.2337/dc11-1162 · Cited by 303
Self-citation
Lifetime Direct Medical Costs of Treating Type 2 Diabetes and Diabetic Complications
Zhuo, X., Zhang, P., & Hoerger, T. J. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2013.04.017 · Cited by 282
Self-citation
Obesity and obstructive sleep apnea – Clinical significance of weight loss
Tuomilehto, H., Seppä, J., & Uusitupa, M. (2013) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2012.08.002 · Cited by 215
Introduction
(2016) · Diabetes Care · doi:10.2337/dc17-s001 · Cited by 200
Cost-effectiveness of diabetes prevention interventions targeting high-risk individuals and whole populations: a systematic review
Zhou, X., Siegel, K. R., Ng, B. P., Jawanda, S., Proia, K. K., Zhang, X., Albright, A. L., & Zhang, P. (2020) · Diabetes Care · doi:10.2337/dci20-0018 · Cited by 173
Self-citation
Validating Retinal Fundus Image Analysis Algorithms: Issues and a Proposal
Trucco, E., Ruggeri, A., Karnowski, T. P., Giancardo, L., Chaum, E., Hubschman, J., Al-Diri, B., Cheung, C. Y.-L., Wong, D. W. K., Abràmoff, M. D., et al. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10347 · Cited by 163
Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008?
Siegel, K. R., Ali, M. K., Zhou, X., Ng, B. P., Jawanda, S., Proia, K. K., Zhang, X., Gregg, E. W., Albright, A. L., & Zhang, P. (2020) · Diabetes Care · doi:10.2337/dci20-0017 · Cited by 168
Self-citation
Insulin Therapy for Type 2 Diabetes Mellitus
Wallia, A., & Molitch, M. E. (2014) · JAMA · doi:10.1001/jama.2014.5951 · Cited by 159
Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force
Li, R., Qu, S., Zhang, P., Chattopadhyay, S. K., Gregg, E. W., Albright, A. L., Hopkins, D. P., & Pronk, N. P. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0469 · Cited by 152
Self-citation
Aging, Diabetes, and the Public Health System in the United States
Caspersen, C. J., Thomas, G. D., Boseman, L. A., Beckles, G. L., & Albright, A. L. (2012) · American Journal of Public Health · doi:10.2105/ajph.2011.300616 · Cited by 162
Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications
Simó, R., & Hernández, C. (2012) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2012-302005 · Cited by 152
Effect of a lifestyle intervention on weight change in south Asian individuals in the UK at high risk of type 2 diabetes: a family-cluster randomised controlled trial
Bhopal, R. S., Douglas, A., Wallia, S., Forbes, J. F., Lean, M. E. J., Gill, J. M. R., McKnight, J. A., Sattar, N., Sheikh, A., Wild, S. H., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70204-3 · Cited by 149
Non-pharmacological interventions to reduce the risk of diabetes in people with impaired glucose regulation: a systematic review and economic evaluation.
Gillett, M., Royle, P., Snaith, A., Scotland, G., Poobalan, A. S., Imamura, M., Black, C., Boroujerdi, M. A., Jick, S. S., Wyness, L., et al. (2012) · Health Technology Assessment · doi:10.3310/hta16330 · Cited by 150
Translating the Diabetes Prevention Program into an Online Social Network: Validation against CDC Standards
Sepah, S. C., Jiang, L., & Peters, A. L. (2014) · The Diabetes Educator · doi:10.1177/0145721714531339 · Cited by 139
The role of community health workers in diabetes: update on current literature
Shah, M., Kaselitz, E., & Heisler, M. (2013) · Current Diabetes Reports · doi:10.1007/s11892-012-0359-3 · Cited by 138
Introduction
(2015) · Diabetes Care · doi:10.2337/dc16-s001 · Cited by 124
Preventing type 2 diabetes: systematic review of studies of cost-effectiveness of lifestyle programmes and metformin, with and without screening, for pre-diabetes
Roberts, S. A., Barry, E., Craig, D., Airoldi, M., Bevan, G., & Greenhalgh, T. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017184 · Cited by 133
Cost-Effectiveness Analysis of a Community Health Worker Intervention for Low-Income Hispanic Adults with Diabetes
Brown, H. S., Wilson, K. J., Pagán, J. A., Arcari, C. M., Martinez, M. L., Smith, K. L., & Reininger, B. M. (2012) · Preventing Chronic Disease · doi:10.5888/pcd9.120074 · Cited by 119
What is the scope of improving immigrant and ethnic minority healthcare using community navigators: A systematic scoping review
Shommu, N. S., Ahmed, S., Rumana, N., Barron, G. R. S., McBrien, K., & Turin, T. C. (2016) · International Journal for Equity in Health · doi:10.1186/s12939-016-0298-8 · Cited by 119
Understanding the Economic Costs of Diabetes and Prediabetes and What We May Learn About Reducing the Health and Economic Burden of These Conditions
O’Connell, J., & Manson, S. M. (2019) · Diabetes Care · doi:10.2337/dci19-0017 · Cited by 137
Differences in incidence of diabetic retinopathy between type 1 and 2 diabetes mellitus: a nine-year follow-up study
Romero‐Aroca, P., Navarro-Gil, R., Valls, A., Sagarra-Alamo, R., Moreno, A., & Soler-Lluís, N. (2017) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2016-310063 · Cited by 112
The effectiveness and cost effectiveness of dark chocolate consumption as prevention therapy in people at high risk of cardiovascular disease: best case scenario analysis using a Markov model
Zomer, E., Owen, A. J., Magliano, D. J., Liew, D., & Reid, C. M. (2012) · BMJ · doi:10.1136/bmj.e3657 · Cited by 108
Antidiabetic Food-Derived Peptides for Functional Feeding: Production, Functionality and In Vivo Evidences
Rivero‐Pino, F., Espejo-Carpio, F. J., & Guadix, E. M. (2020) · Foods · doi:10.3390/foods9080983 · Cited by 107
Screening for Diabetes and Prediabetes
Duan, D., Kengne, A. P., & Echouffo-Tcheugui, J. B. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.05.002 · Cited by 131
Patient-Driven Diabetes Care of the Future in the Technology Era
Ashrafzadeh, S., & Hamdy, O. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.005 · Cited by 111
Diabetes in the Western Pacific Region—Past, Present and Future
Chan, J. C. N., Cho, N. H., Tajima, N., & Shaw, J. E. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.012 · Cited by 99
Application of Artificial Intelligence in Diabetes Education and Management: Present Status and Promising Prospect
Li, J., Huang, J., Zheng, L., & Li, X. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00173 · Cited by 110
Lifestyle Interventions to Prevent Type 2 Diabetes: A Systematic Review of Economic Evaluation Studies
Alouki, K., Delisle, H. F., Bermúdez‐Tamayo, C., & Johri, M. (2016) · Journal of Diabetes Research · doi:10.1155/2016/2159890 · Cited by 94
Metabolomics based markers predict type 2 diabetes in a 14-year follow-up study
Liu, J., Semiz, S., van der Lee, S. J., van der Spek, A., Verhoeven, A., van Klinken, J. B., Sijbrands, E. J. G., Harms, A. C., Hankemeier, T., van Dijk, K. W., et al. (2017) · Metabolomics · doi:10.1007/s11306-017-1239-2 · Cited by 94
Introduction
(2014) · Diabetes Care · doi:10.2337/dc15-s001 · Cited by 116
Smoking cessation predicts amelioration of microalbuminuria in newly diagnosed type 2 diabetes mellitus: a 1-year prospective study
Voulgari, C., Katsilambros, N., & Tentolouris, N. (2011) · Metabolism · doi:10.1016/j.metabol.2011.02.014 · Cited by 90
Medical Care and Payment for Diabetes in China: Enormous Threat and Great Opportunity
Yang, W., Zhao, W., Xiao, J., Li, R., Zhang, P., Kissimova‐Skarbek, K., Schneider, E., Jia, W., Ji, L., Guo, X., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039513 · Cited by 93
Self-citation
Diabetes Associated With Early Labor-Force Exit: A Comparison Of Sixteen High-Income Countries
Rumball‐Smith, J., Barthold, D., Nandi, A., & Heymann, J. S. (2014) · Health Affairs · doi:10.1377/hlthaff.2013.0518 · Cited by 85
Challenges in adult vaccination
de Gomensoro, E., Giudice, G. D., & Doherty, T. M. (2018) · Annals of Medicine · doi:10.1080/07853890.2017.1417632 · Cited by 85
Review of the role of cigarette smoking in diabetic foot
Xia, N., Morteza, A., Yang, F., Cao, H., & Wang, A. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12952 · Cited by 98
A systematic literature review of diabetes self-management education features to improve diabetes education in women of Black African/Caribbean and Hispanic/Latin American ethnicity
Gucciardi, E., Chan, V. W.-S., Manuel, L., & Sidani, S. (2013) · Patient Education and Counseling · doi:10.1016/j.pec.2013.03.007 · Cited by 95
Cost-effectiveness of a diabetes group education program delivered by health promoters with a guiding style in underserved communities in Cape Town, South Africa
Mash, R. J., Kroukamp, R., Gaziano, T., & Levitt, N. S. (2015) · Patient Education and Counseling · doi:10.1016/j.pec.2015.01.005 · Cited by 76
A story of metformin-butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: Genesis of a wonder drug?
Maniar, K., Moideen, A., Mittal, A., Patil, A., Chakrabarti, A., & Banerjee, D. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.003 · Cited by 75
Efficacy and cost-effectiveness of fecal immunochemical test versus colonoscopy in colorectal cancer screening: a systematic review and meta-analysis
Zhong, G., Sun, W., Wan, L., Hu, J., & Hao, F. (2019) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2019.11.035 · Cited by 72
Smoking and vascular risk: are all forms of smoking harmful to all types of vascular disease?
Katsiki, N., Papadopoulou, S. Κ., Fachantidou, A., & Mikhailidis, D. P. (2013) · Public Health · doi:10.1016/j.puhe.2012.12.021 · Cited by 71
Losing a foot versus losing a dollar; a systematic review of cost studies in diabetic foot complications
Petrakis, I. E., Kyriopoulos, I., Ginis, A., & Athanasakis, K. (2017) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2017.1305891 · Cited by 68
A Nationwide Community-Based Lifestyle Program Could Delay Or Prevent Type 2 Diabetes Cases And Save $5.7 Billion In 25 Years
Zhuo, X., Zhang, P., Gregg, E. W., Barker, L., Hoerger, T. J., Pearson-Clarke, T., & Albright, A. (2012) · Health Affairs · doi:10.1377/hlthaff.2011.1115 · Cited by 82
Self-citation
The Association Between Poor Glycemic Control and Health Care Costs in People With Diabetes: A Population-Based Study
Mata‐Cases, M., Rodríguez-Sánchez, B., Mauricio, D., Real, J., Vlacho, B., Franch‐Nadal, J., & Oliva, J. (2020) · Diabetes Care · doi:10.2337/dc19-0573 · Cited by 67
The Case for Diabetes Population Health Improvement: Evidence-Based Programming for Population Outcomes in Diabetes
Golden, S. H., Maruthur, N. M., Mathioudakis, N. N., Spanakis, E. K., Rubin, D. J., Zilbermint, M. F., & Hill‐Briggs, F. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0875-2 · Cited by 68
Barriers to diabetic foot care in a developing country with a high incidence of diabetes related amputations: an exploratory qualitative interview study
Guell, C., & Unwin, N. C. (2015) · BMC Health Services Research · doi:10.1186/s12913-015-1043-5 · Cited by 61
The Economics of Diabetes Prevention
Herman, W. H. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2010.11.010 · Cited by 58
The Challenges and Recommendations for Gestational Diabetes Mellitus Care in India: A Review
Morampudi, S., Balasubramanian, G. V., Gowda, A., Zomorodi, B., & Patil, A. S. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00056 · Cited by 60
Multidisciplinary collaborative care in the management of patients with uncontrolled diabetes: A systematic review and meta-analysis
Siaw, M. Y. L., & Lee, J. V. (2018) · International Journal of Clinical Practice · doi:10.1111/ijcp.13288 · Cited by 66
Screening for Diabetes and Prediabetes Should Be Cost-Saving in Patients at High Risk
Chatterjee, R., Narayan, K. M. V., Lipscomb, J., Jackson, S. L., Long, Q., Ming, Z., & Phillips, L. S. (2013) · Diabetes Care · doi:10.2337/dc12-1752 · Cited by 61
MicroRNA-1281 as a Novel Circulating Biomarker in Patients With Diabetic Retinopathy
Greco, M., CHIEFARI, E. D., Accattato, F., Corigliano, D. M., Arcidiacono, B., Mirabelli, M., Liguori, R., Brunetti, F. S., Pullano, S. A., Scorcia, V., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00528 · Cited by 57
Cost-effectiveness of healthy eating and/or physical activity promotion in pregnant women at increased risk of gestational diabetes mellitus: economic evaluation alongside the DALI study, a European multicenter randomized controlled trial
Broekhuizen, K., Simmons, D. S., Devlieger, R., Assche, A. V., Jans, G., Galjaard, S., Corcoy, R., Adelantado, J. M., Dunne, F., Desoyé, G., et al. (2018) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-018-0643-y · Cited by 60
Cost-Effectiveness of Frequent HIV Testing of High-Risk Populations in the United States
Hutchinson, A. B., Farnham, P. G., Sansom, S. L., Yaylalı, E., & Mermin, J. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000838 · Cited by 56
Prevention of foot ulcers in the at‐risk patient with diabetes: a systematic review
van Netten, J. J., Raspovic, A., Lavery, L. A., Monteiro‐Soares, M., Rasmussen, A., Sacco, I. C. N., & Bus, S. A. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3270 · Cited by 216
Cost-Effectiveness of Therapeutic Education to Prevent the Development and Progression of Type 2 Diabetes: Systematic Review
Odnoletkova, I. (2014) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000438 · Cited by 56
Cost-effectiveness of GLP-1 receptor agonists versus insulin for the treatment of type 2 diabetes: a real-world study and systematic review
Yang, C.-Y., Chen, Y.-R., Ou, H.-T., & Kuo, S. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01211-4 · Cited by 51
Diabetes self-management education and medical nutrition therapy: a multisite study documenting the efficacy of registered dietitian nutritionist interventions in the management of glycemic control and diabetic dyslipidemia through retrospective chart review
Marincic, P. Z., Salazar, M. V., Hardin, A., Scott, S., Fan, S. X., Gaillard, P. R., Wyatt, C., Watson, L., Green, P., Glover, P., et al. (2019) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2018.06.303 · Cited by 51
Cost-Effectiveness of Hepatitis B Vaccination in Adults With Diagnosed Diabetes
Hoerger, T. J., Schillie, S. F., Wittenborn, J. S., Bradley, C. L., Zhou, F., Byrd, K. K., & Murphy, T. V. (2012) · Diabetes Care · doi:10.2337/dc12-0759 · Cited by 51
Economic evaluation of type 2 diabetes prevention programmes: Markov model of low- and high-intensity lifestyle programmes and metformin in participants with different categories of intermediate hyperglycaemia
Roberts, S., Craig, D., Adler, A., McPherson, K., & Greenhalgh, T. (2018) · BMC Medicine · doi:10.1186/s12916-017-0984-4 · Cited by 48
Diabetes: An Update on the Pandemic and Potential Solutions
Ali, M. K., Siegel, K. R., Chandrasekar, E. K., Tandon, N., Montoya, P. A., Mbanya, J. C., Chan, J. C. N., Zhang, P., & Narayan, K. M. V. (2017) · World Bank, Washington, DC eBooks · doi:10.1596/978-1-4648-0518-9_ch12 · Cited by 45
Self-citation
Identification of the differential expression of serum microRNA in type 2 diabetes
Ding, L., Ai, D., Wu, R., Zhang, T., Jing, L., Lü, J., & Zhong, L. (2015) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2015.1107460 · Cited by 45
Hypertension, diabetes and lifestyle in the long-term — Results from a Swiss population-based cohort
Walther, D., Curjuric, I., Dratva, J., Schaffner, E., Quinto, C. B., Schmidt‐Trucksäss, A., Eze, I. C., Burdet, L., Pons, M., Gerbase, M. W., et al. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.12.016 · Cited by 47
The impact of diabetes mellitus on healthcare costs in Italy
Giorda, C. B., Manicardi, V., & Diago, J. I. (2011) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.11.78 · Cited by 44
The Community Diabetes Education (CoDE) Program
Prezio, E. A., Pagán, J. A., Shuval, K., & Culica, D. V. (2014) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2014.08.016 · Cited by 44
Comparison between binocular indirect ophthalmoscopy and digital retinography for diabetic retinopathy screening: the multicenter Brazilian Type 1 Diabetes Study
On behalf of The Brazilian Type 1 Diabetes Study Group, Malerbi, F. K., Morales, P. H., Farah, M. E., Drummond, K. R. G., Mattos, T. C. L., Pinheiro, A. A., Mallmann, F., Perez, R. V., Leal, F. S. L., et al. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0110-8 · Cited by 44
Comparing Treatment Modalities For End-Stage Renal Disease: A Meta-Analysis
Queeley, G. L., & Campbell, E. S. (2014) · Value in Health · doi:10.1016/j.jval.2014.03.1690 · Cited by 43
Obstructive Sleep Apnea Is a Predictor of Abnormal Glucose Metabolism in Chronically Sleep Deprived Obese Adults
Cizza, G., Piaggi, P., Lucassen, E. A., de Jonge, L., Walter, M. F., Mattingly, M. S., Kalish, H. R., Csákó, G., Rother, K. I., & the Sleep Extension Study Group (2013) · PLoS ONE · doi:10.1371/journal.pone.0065400 · Cited by 44
The COMPASS initiative: description of a nationwide collaborative approach to the care of patients with depression and diabetes and/or cardiovascular disease
Coleman, K. J., Magnan, S. J., Neely, C., Solberg, L. I., Beck, A. L., Trevis, J., Heim, C., Williams, M., Katzelnick, D. J., Unützer, J., et al. (2016) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2016.05.007 · Cited by 44
Effectiveness of Diabetes Self-Management Education on Quality of Life in Diabetic Elderly Females
Jahromi, M. K., Ramezanli, S., & Taheri, L. (2014) · Global Journal of Health Science · doi:10.5539/gjhs.v7n1p10 · Cited by 44
Links between maternal health and NCDs
Kapur, A. (2014) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2014.04.016 · Cited by 44
Should Europe follow the US and declare obesity a disease?: a discussion of the so-called utilitarian argument
Vallgårda, S., Nielsen, M. E. J., Hansen, A. K., Cathaoir, K. Ó., Hartlev, M., Holm, L., Christensen, B., Jensen, J. D., Sørensen, T. I. A., & Sandøe, P. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.103 · Cited by 48
Mobile Health Is Worth It! Economic Benefit and Impact on Health of a Population-Based Mobile Screening Program in New Mexico
Brown-Connolly, N. E., Concha, J. B., & English, J. (2013) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2013.0080 · Cited by 41
Cost-Effectiveness Analysis of Treatments for Vertebral Compression Fractures
Edidin, A. A., Ong, K. L., Lau, E., Schmier, J. K., Kemner, J. E., & Kurtz, S. M. (2012) · Applied Health Economics and Health Policy · doi:10.2165/11633220-000000000-00000 · Cited by 42
Diagnosis of Diabetes by Applying Data Mining Classification Techniques
Daghistani, T., & Alshammari, R. (2016) · International Journal of Advanced Computer Science and Applications · doi:10.14569/ijacsa.2016.070747 · Cited by 40
Projecting diabetes prevalence among Mexicans aged 50 years and older: the Future Elderly Model-Mexico (FEM-Mexico)
González‐González, C., Tysinger, B., Goldman, D. P., & Wong, R. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017330 · Cited by 40
The Association Between Patient-Reported Self-management Behavior, Intermediate Clinical Outcomes, and Mortality in Patients With Type 2 Diabetes: Results From the KORA-A Study
Laxy, M., Mielck, A., Hünger, M., Schunk, M. V., Meisinger, C., Rückert, I., Rathmann, W., & Holle, R. (2014) · Diabetes Care · doi:10.2337/dc13-2533 · Cited by 41
Economic Evaluation of Quality Improvement Interventions Designed to Improve Glycemic Control in Diabetes: A Systematic Review and Weighted Regression Analysis
Nuckols, T. K., Keeler, E. B., Anderson, L., Green, J., Morton, S. C., Doyle, B. J., Shetty, K. D., Arifkhanova, A., Booth, M. S., Shanman, R., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1495 · Cited by 40
Cost-Utility Analyses in Diabetes: A Systematic Review and Implications from Real-World Evidence
Zhong, Y., Lin, P., Cohen, J. T., Winn, A. N., & Neumann, P. J. (2015) · Value in Health · doi:10.1016/j.jval.2014.12.004 · Cited by 37
Benefit-Risk Assessment of Alogliptin for the Treatment of Type 2 Diabetes Mellitus
Kaku, K., Kisanuki, K., Shibata, M., & Oohira, T. (2019) · Drug Safety · doi:10.1007/s40264-019-00857-8 · Cited by 39
Type 2 diabetes treatment intensification in general practice in France in 2008–2009: the DIAttitude Study
Balkau, B., Bouée, S., Avignon, A., Vergès, B. L., Chartier, I., Amelineau, E., & Halimi, S. (2012) · Diabetes & Metabolism · doi:10.1016/s1262-3636(12)71532-x · Cited by 38
Regional Primary Care Team to Deliver Best-Practice Diabetes Care
Segal, L., Leach, M., May, E., & Turnbull, C. (2013) · Diabetes Care · doi:10.2337/dc12-1793 · Cited by 37

Authors: Li, R., Zhang, P., Barker, L. E., Chowdhury, F. M., & Zhang, X.
Affiliations: Centers for Disease Control and Prevention (US)
Corresponding author: Li, Rui
ORCID: Li, Rui
Zhang, Ping
Zhang, Xuanping
Venue: Diabetes Care
Publisher: American Diabetes Association
Published: 2010-08-01
Volume: 33
Issue: 8
Pages: 1872-1894
ISSN: 0149-5992 (ISSN-L)
1935-5548
DOI: 10.2337/dc10-0843
PMC: PMC2909081
OpenAlex: W2101430875
Cited by: 491
References: 87
Citations by year: 2026: 11 · 2025: 25 · 2024: 22 · 2023: 13 · 2022: 24 · 2021: 35 · 2020: 36 · 2019: 24 · 2018: 33 · 2017: 33 · 2016: 40 · 2015: 37 · 2014: 41 · 2013: 50 · 2012: 42
FWCI: 9.76
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
creativecommons.org/licenses/by-nc-nd/3.0/ (vor, 4049 d)
Locations: Diabetes Care (publishedVersion, cc-by-nc-nd)
PubMed Central (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
Topics: Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords: cost-effectiveness, diabetes prevention, diabetes complications, diabetes comorbidity, ACE inhibitors, angiotensin receptor blockers, end-stage renal disease prevention, irbesartan, microalbuminuria, diabetic foot ulcer prevention, type 1 diabetes, type 2 diabetes, tight glycemic control, lifestyle intervention, impaired glucose tolerance, diabetes screening, statin therapy, smoking cessation
MeSH terms: Cost-Benefit Analysis, Diabetes Mellitus, Humans, Quality-Adjusted Life Years

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks